Novo Nordisk Postdoctoral Research Fellow
I studied clinical medicine at Shanghai Jiao Tong University, China, graduating in 2013. I then undertook a one-year research training placement on the clinical epidemiology of type 2 diabetes at the Department of Endocrine and Metabolic Diseases in Rui-Jin Hospital, Shanghai. After I obtained my MSc degree in genetic epidemiology at Erasmus Medical Center in Rotterdam, Netherlands, I continued as a scientific researcher and was awarded my PhD degree (thesis title: Integration of Multi-Omics in Type 2 Diabetes and Related Disorders Research). In 2019, I moved to Oxford and joined the Nuffield Department of Population Health (NDPH), University of Oxford, for my first postdoctoral position. I continued working on implementing novel analytic approaches to high-dimensional analysis, and during this time I used UK Biobank data to integrate multi-omics in cardiometabolic diseases and related neurological disorders.
From September 2021, I started my Novo Nordisk Research Fellowship working with Professor Cornelia van Duijn (NDPH) and Dr Joanna Howson (Novo Nordisk Research Centre Oxford) on a project entitled, "An Integrative Cross-omics Study of Non-Alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis".
Circulating inflammatory cytokines and female reproductive diseases: a Mendelian randomization analysis.
Lin Y. et al, (2023), J Clin Endocrinol Metab
Author Correction: The power of genetic diversity in genome-wide association studies of lipids.
Graham SE. et al, (2023), Nature
Longitudinal analysis of UK Biobank participants suggests age and APOE-dependent alterations of energy metabolism in development of dementia
Liu J. et al, (2022)
Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges.
Wang C. et al, (2022), Trends Genet
A multi-omics study of circulating phospholipid markers of blood pressure.
Liu J. et al, (2022), Sci Rep, 12